The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Advaxis Inc. | COM NEW | 7624208 | 2,813 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Advaxis Inc. | W EXP 07/15/201 | 7624117 | 731 | 112,500 | SH | SOLE | 112,500 | 0 | 0 | ||
Alcobra Ltd | SHS | M2239P109 | 6,737 | 1,115,315 | SH | SOLE | 1,115,315 | 0 | 0 | ||
Aldeyra Therapeutics Inc | COM | 01438T106 | 792 | 135,800 | SH | SOLE | 135,800 | 0 | 0 | ||
Ampio Pharmaceuticals Inc. | COM | 03209T109 | 9,792 | 3,388,322 | SH | SOLE | 3,388,322 | 0 | 0 | ||
Aptose Biosciences Inc | COM NEW | 03835T200 | 51 | 11,933 | SH | SOLE | 11,933 | 0 | 0 | ||
Bio Blast Pharma Ltd | SHS | M20156101 | 1,721 | 338,110 | SH | SOLE | 338,110 | 0 | 0 | ||
Caladrius Biosciences Inc | COM | 128058104 | 1,490 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
Corbus Pharmaceuticals HLDGS | COM | 21833P103 | 4,325 | 2,750,000 | SH | SOLE | 2,750,000 | 0 | 0 | ||
Evoke Pharma Inc | COM | 30049G104 | 162 | 55,660 | SH | SOLE | 55,660 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd | SHS | M47238106 | 483 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
Keryx Biopharmaceuticals Inc. | COM | 492515101 | 704 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Lion Biotechnologies Inc | COM | 53619R102 | 559 | 97,100 | SH | SOLE | 97,100 | 0 | 0 | ||
Medivation, Inc. | COM | 58501N101 | 186,908 | 4,397,838 | SH | SOLE | 4,397,838 | 0 | 0 | ||
Newlink Genetics Corp | COM | 651511107 | 3,671 | 102,437 | SH | SOLE | 102,437 | 0 | 0 | ||
OHR Pharmaceutical Inc | COM NEW | 67778H200 | 566 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
Abeona Therapeutics Inc | COM | 00289Y107 | 5,507 | 1,359,767 | SH | SOLE | 1,359,767 | 0 | 0 | ||
Synthetic Biologics Inc. | COM | 87164U102 | 8,477 | 3,734,149 | SH | SOLE | 3,734,149 | 0 | 0 | ||
Zosano Pharma Corp | COM | 98979H103 | 74 | 18,600 | SH | SOLE | 18,600 | 0 | 0 |